240 related articles for article (PubMed ID: 25636447)
1. Prognostic value of soluble H7-B4 in pleural effusion associated with lung cancer.
Xu CH; Cao L; Zhang XW; Yan J; Yu LK
Tumour Biol; 2015 Jun; 36(6):4397-403. PubMed ID: 25636447
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion.
Xu C; Qian L; Yu L; Zhang X; Wang Q
Biomarkers; 2015; 20(4):271-4. PubMed ID: 26301886
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of soluble B7-H4 in malignant pleural effusion].
Xu CH; Yu LK
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(2):117-8. PubMed ID: 22490695
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis value of serum soluble B7-H4 expression in non-small cell lung cancer.
Xu CH; Wang W; Wang YC; Lin Y; Zhang XW
Clin Respir J; 2018 Jan; 12(1):134-139. PubMed ID: 27216449
[TBL] [Abstract][Full Text] [Related]
6. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
7. Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion.
Yang J; Zhu Y; Wu L; Zhu W; Zhang X; Yang Y; Xu C
Clin Respir J; 2018 Jan; 12(1):279-284. PubMed ID: 27402224
[TBL] [Abstract][Full Text] [Related]
8. Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients.
Xu C; Yu L; Zhan P; Zhang Y
Eur J Med Res; 2014 May; 19(1):23. PubMed ID: 24887477
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of soluble B7-H3 in NSCLC-derived malignant pleural effusion: A potential diagnostic biomarker correlated with NSCLC staging.
Chen L; Zhang G; Sheng S; Zhou Q; Pan Y; Guan S
Clin Chim Acta; 2016 Jun; 457():81-5. PubMed ID: 27071700
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of serum B7-H4 for hepatocellular carcinoma.
Zhang C; Li Y; Wang Y
J Surg Res; 2015 Aug; 197(2):301-6. PubMed ID: 25963168
[TBL] [Abstract][Full Text] [Related]
12. B7-H4 expression is associated with tumor progression and prognosis in patients with osteosarcoma.
Dong Q; Ma X
Biomed Res Int; 2015; 2015():156432. PubMed ID: 25954746
[TBL] [Abstract][Full Text] [Related]
13. Analysis of B7-H4 expression in metastatic pleural adenocarcinoma and therapeutic potential of its antagonists.
Chen C; Qu QX; Xie F; Zhu WD; Zhu YH; Huang JA
BMC Cancer; 2017 Sep; 17(1):652. PubMed ID: 28923053
[TBL] [Abstract][Full Text] [Related]
14. Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer.
Shi H; Ji M; Wu J; Zhou Q; Li X; Li Z; Zheng X; Xu B; Zhao W; Wu C; Jiang J
World J Surg Oncol; 2014 Jun; 12():188. PubMed ID: 24947047
[TBL] [Abstract][Full Text] [Related]
15. Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia.
Mach P; Nolte-Boenigk L; Droste L; Fox L; Frank M; Schmidt B; Herse F; Verlohren S; Wicherek L; Iannaccone A; Birdir C; Andrikos D; Kimmig R; Gellhaus A; Köninger A
Am J Reprod Immunol; 2018 Sep; 80(3):e12988. PubMed ID: 29797540
[TBL] [Abstract][Full Text] [Related]
16. The expression and clinical significance of B7-H3 and miR-145 in lung cancer patients with malignant pleural effusion.
Huang L
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6759-6766. PubMed ID: 32633367
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions.
Park DS; Kim D; Hwang KE; Hwang YR; Park C; Seol CH; Cho KH; Kim BR; Park SH; Jeong ET; Kim HR
Yonsei Med J; 2013 Mar; 54(2):396-402. PubMed ID: 23364973
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
20. Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patients.
Aoe K; Hiraki A; Yamazaki K; Nakamura Y; Murakami T; Maeda T; Nishimura M; Sugi K; Ueoka H
Int J Oncol; 2006 Jul; 29(1):65-72. PubMed ID: 16773186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]